You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tamoxifen

Showing 51 - 75 of 865
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer Trial (Elacestrant, Tamoxifen, Letrozole 2.5mg)

Not yet recruiting
  • ER-positive Breast Cancer
  • +3 more
  • (no location specified)
Aug 22, 2022

Early-stage Breast Cancer Trial in Ottawa (Endocrine Therapy and Radiotherapy)

Completed
  • Early-stage Breast Cancer
  • Endocrine Therapy and Radiotherapy
  • Ottawa, Ontario, Canada
    Ottawa Hospital Research Institute
Sep 28, 2022

Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast Cancer Trial in Stanford (Alpelisib, Tamoxifen, Infigratinib)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Stanford, California
    Stanford University
Nov 16, 2022

Breast Tumors Trial in Mönchengladbach (drug, diagnostic test, procedure)

Active, not recruiting
  • Breast Neoplasms
  • Perjeta Injectable Product
  • +13 more
  • Mönchengladbach, Germany
    Evangelisches Krankenhaus Bethesda Mönchengladbach
Oct 4, 2022

Breast Cancer Trial in New York (Fulvestrant, Tamoxifen)

Terminated
Has Results
  • Breast Cancer
  • New York, New York
  • +2 more
Apr 27, 2021

Breast Cancer Trial in Amsterdam (anthracycline-based, docetaxel and capecitabine, tamoxifen)

Completed
  • Breast Cancer
  • Amsterdam, Netherlands
    Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Nov 16, 2022

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer Trial in

Terminated
Has Results
  • Estrogen Receptor-positive Breast Cancer
  • +7 more
  • Atlanta, Georgia
  • +2 more
Mar 10, 2022

Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma Trial in United States (Abemaciclib, Tamoxifen,

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +7 more
Aug 14, 2023

Breast Cancer Trial in Worldwide (Amcenestrant, Tamoxifen, Amcenestrant-matching )

Active, not recruiting
  • Breast Cancer
  • East Syracuse, New York
  • +52 more
Aug 18, 2022

X Linked Myotubular Myopathy Trial in Canada, United Kingdom, United States (ApoTamox 10mg, Placebo)

Recruiting
  • X Linked Myotubular Myopathy
  • ApoTamox 10mg
  • Placebo
  • Chicago, Illinois
  • +3 more
Jun 17, 2021

Breast Cancer, Quality of Life Trial in Chapel Hill (Accelerated Partial Breast Irradiation (APBI), tamoxifen, anastrozole,

Recruiting
  • Breast Cancer
  • Quality of Life
  • Accelerated Partial Breast Irradiation (APBI)
  • tamoxifen, anastrozole, exemestane, letrozole, fulvestrant, toremifene
  • Chapel Hill, North Carolina
    University of North Carolina
Jul 22, 2022

Non Metastatic Breast Cancer Trial in Lyon, Paris, Saint Herblain (tamoxifen)

Completed
  • Non Metastatic Breast Cancer
  • tamoxifen
  • Lyon, France
  • +2 more
Mar 10, 2021

Mammographically Dense Breast Trial in United States (Afimoxifene, Laboratory Biomarker Analysis, Placebo)

Active, not recruiting
  • Mammographically Dense Breast
  • Tampa, Florida
  • +4 more
Dec 27, 2022

Breast Cancer, HER2-positive Trial in Houston (Zanidatamab, Letrozole, Tamoxifen)

Recruiting
  • Breast Cancer
  • HER2-positive
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

Bladder Cancer Trial in Houston (Tamoxifen Citrate)

Completed
Has Results
  • Bladder Cancer
  • Tamoxifen Citrate
  • Houston, Texas
  • +1 more
Dec 18, 2020

Early-stage Breast Cancer Trial (Tamoxifen alone, Tamoxifen + Aminoglutethimide)

Completed
  • Early-stage Breast Cancer
  • Tamoxifen alone
  • Tamoxifen + Aminoglutethimide
  • (no location specified)
Oct 13, 2020

Breast Cancer, Estrogen Receptor-positive Breast Cancer Trial in Charlottesville (Aspirin, Tamoxifen Pill, Doxorubicin)

Withdrawn
  • Breast Cancer
  • Estrogen Receptor-positive Breast Cancer
  • Charlottesville, Virginia
    University of Virginia
Nov 12, 2021

The Ultrasound Study of Tamoxifen

Completed
  • Breast Neoplasms
    • Detroit, Michigan
      Henry Ford Health Systems
    Dec 23, 2020

    Breast Cancer Female Trial in Charlottesville, Richmond (tamoxifen, letrozole, anastrozole, or exemestane, Patient reported

    Recruiting
    • Breast Cancer Female
    • tamoxifen, letrozole, anastrozole, or exemestane
    • Patient reported outcomes
    • Charlottesville, Virginia
    • +1 more
    Mar 16, 2022

    Metastatic Breast Cancer Trial in Guangzhou, Shantou (Mecapegfilgrastim, dalpiciclib, exemestane, fulvestrant, letrozole,

    Not yet recruiting
    • Metastatic Breast Cancer
    • Guangzhou, Guangdong, China
    • +2 more
    Jul 17, 2022

    Ductal Breast Carcinoma In Situ, Estrogen Receptor Positive Trial in United States (Afimoxifene, Laboratory Biomarker Analysis,

    Recruiting
    • Ductal Breast Carcinoma In Situ
    • Estrogen Receptor Positive
    • Chicago, Illinois
    • +5 more
    Dec 17, 2020

    Breast Cancer Trial in Budapest (Tamoxifen, Goserelin, Letrozole 2.5Mg Tab)

    Not yet recruiting
    • Breast Cancer
    • Tamoxifen
    • +9 more
    • Budapest, Hungary
      National Institute of Oncolgy
    Nov 20, 2021

    Breast Cancer Trial in Duarte (biological, drug, procedure)

    Active, not recruiting
    Has Results
    • Breast Cancer
    • filgrastim
    • +10 more
    • Duarte, California
      City of Hope Comprehensive Cancer Center
    Feb 17, 2022

    Breast Cancer Trial in Nijmegen (Tamoxifen 40mg QD)

    Completed
    • Breast Cancer
    • Tamoxifen 40mg QD
    • Nijmegen, Netherlands
      Radboud University Nijmegen Medical Centre
    Nov 26, 2020

    Early-Stage Breast Carcinoma, Estrogen Receptor Positive Tumor Trial in Stockholm (Paclitaxel, Tamoxifen + Palbociclib,

    Active, not recruiting
    • Early-Stage Breast Carcinoma
    • Estrogen Receptor Positive Tumor
    • Stockholm, Sweden
    • +2 more
    Jul 30, 2021